摘要
目的:分析食管癌核心家系患者的临床病理特征及术后预后影响因素。方法:收集3 260例接受食管癌根治性切除手术的、来自于不同食管癌核心家系的患者的临床病理资料和随访信息,分析食管癌核心家系患者的临床病理特征及术后预后影响因素。结果:3 260例食管鳞癌患者男女比例为1. 7∶1,确诊年龄32~85(60. 2±8. 1)岁,≥60岁者占53. 8%; 88. 8%来自食管癌高发区;肿瘤位于食管中段和下段者占82. 5%;低、中、高分化者分别占26. 6%、61. 9%和11. 5%;切缘净占94. 3%;肿瘤长径<4 cm者占47. 6%; TNM分期(0+Ⅰ)期占15. 2%,Ⅱ、Ⅲ、Ⅳ期者分别占54. 5%、29. 9%和0. 4%。Cox分析结果显示,男性、确诊年龄≥60岁、肿瘤位于食管颈段和上段、分化程度低、肿瘤长径≥4 cm和TNM晚期是食管癌核心家系患者术后预后的独立危险因素,HR(95%CI)分别为1. 119(1. 016~1. 231)、1. 302 (1. 185~1. 429)、1. 345 (1. 186~1. 526)、1. 149 (1. 065~1. 238)、1. 269 (1. 151~1. 400)、1. 666(1. 547~1. 795)。结论:性别、确诊年龄、肿瘤部位、分化程度、肿瘤长径及TNM分期是食管癌核心家系患者术后预后的影响因素。
Aim: To analyze the clinicopathological features and postoperation prognosis of patients from core family of esophageal cancer. Methods: The clinical pathological data and follow-up information of 3 260 esophageal squamous cell carcinoma( ESCC) patients from different core families and undergoing radical resection of esophageal cancer were collected,and the clinicopathological features and prognosis were retrospectively analyzed. Results: Among the 3 260 patients,the ratio of men to women was 1. 7∶ 1,the age at diagnosis was 32-85( 60. 2 ± 8. 1) years,53. 8% patients was more than60 years old; 88. 8% came from the high-incidence area; 26. 6%,61. 9% and 11. 5% were with low,medium,and high differentiation,respectively; 94. 3% had postoperative margin clearance; the patients with tumor long diameter < 4 cm accounted for 47. 6%; the proportion of the patients with TNM 0 + Ⅰ,Ⅱ,Ⅲ,Ⅳ stage were 15. 2%,54. 5%,29. 9% and 0. 4%,respectively. The results of Cox regression showed that males,age at diagnosis≥60 years,tumor segment + upper segment,low degree of differentiation,tumor long diameter ≥4 cm and late TNM stage were the risk factors for the postoperation prognosis,and HR( 95% CI) was 1. 119( 1. 016-1. 231),1. 302( 1. 185-1. 429),1. 345( 1. 186-1. 526),1. 149( 1. 065-1. 238),1. 269( 1. 151-1. 400),1. 666( 1. 547-1. 795),respectively. Conclusion: Gender,age at diagnosis,location of tumor,degree of differentiation,length of tumor,and TNM stage may be the influencing factors of postoperation prognosis for ESCC patients from esophageal cancer core family.
引文
[1]CHEN W,SUN K,ZHENG R,et al.Cancer incidence and mortality in China,2014[J].Chin J Cancer Res,2018,30(1):1
[2]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394
[3]PARKIN D M,LAARA E,MUIR CS.Estimates of the worldwide frequency of sixteen major cancers in 1980[J].Int J Cancer,1988,41(2):184
[4]李卫东,王秀琴,张春林.山西省阳泉市部分人口食管癌遗传流行病学调查[J].中华医学杂志,1998,78(3):203
[5]孙兆刚,侯瑞,王静.一家系四例食管癌[J].中华医学遗传学杂志,1993,10(3):187
[6]蒋长生.胃、食管癌:多发家系报告[J].中国肿瘤临床,1990,17(1):62
[7]姚鹏飞,张桂兰.家族性食管癌二家系[J].遗传与疾病,1987(1):14
[8]李琮宇,李苹娟,吴会芳,等.河南食管癌高发区食管癌高癌家族调查[J].郑州大学学报(医学版),2006,41(1):32
[9]石丘玲,徐德忠.林州市食管癌家族聚集性分析[J].解放军预防医学杂志,2001,19(2):269
[10]常志伟,王立东,高珊珊,等.家族性食管癌组织中FHIT、p53蛋白的表达[J].郑州大学学报(医学版),2006,41(1):24
[11]WANG JM,XU B,HSIEH CC,et al.Longitudinal trends of stomach cancer and esophageal cancer in Yangzhong County:a high-incidence rural area of China[J].Eur J Gastroenterol Hepatol,2005,17(12):101
[12]应江伟,蔡红卫,李辉章,等.2010~2014年浙江省肿瘤登记地区食管癌发病与死亡分析[J].中国肿瘤,2019,28(2):88
[13]HE J,ZENG ZC,SHI SM,et al.Clinical features,outcomes and treatment-related pneumonitis in elderly patients with esophageal carcinoma[J].World J Gastroenterol,2014,20(36):13185
[14]刘海燕,陈军贤,赵秋枫,等.杭州地区食管癌发病危险因素分析[J].中国公共卫生,2014,30(6):842
[15]杨煜,张晓彬,叶波,等.颈段食管癌的外科治疗效果分析[J].中华胸部外科电子杂志,2017,4(2):78
[16]张颖博.中上段食管癌手术治疗观察[J].中国现代药物应用,2015,9(24):21
[17]郭睿,杨勇伟,金澄宇,等.食管癌淋巴结转移的危险因素分析[J].中华胃食管反流病电子杂志,2018,5(1):7
[18]吕双,宋昕,赵学科,等.食管鳞癌肿瘤最大长径与浸润深度(T分期)的关系[J].郑州大学学报(医学版),2017,52(5):522
[19]张唐娟,李印,韩渭丽,等.食管鳞癌肿瘤最大长径与淋巴结转移的关系[J].河南医学研究,2016,25(5):773
[20]崔纪丽,侯志超,刘玉,等.食管癌患者肿瘤最长径与浸润深度和淋巴结转移的关系及其对生存期的影响[J].肿瘤防治研究,2014,41(3):214